Docket Number:12T-1020410
Inventor:Sheau-Yann Shieh
IP Status:Know-how
Abstract:
B cell translocation gene 3 (BTG3) is a candidate tumor suppressor functionally involved in maintaining cell cycle checkpoints and genomic stability. Downregulation of BTG3 has been reported in several human cancers. The antibody was raised against full-length recombinant BTG3 and can detect BTG3 in cells or tissues.
Fields of Application:
The antibody effectively detects endogenous BTG3 in IHC, IF, and IB.
Advantages when compared to the existing technologies:
There is no existing BTG3 antibody with comparable capacity.
Contact Person:Mei-Fang Lee / 886-2-2787-2503 / mflee@gate.sinica.edu.tw
